GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (AQSE:ANA) » Definitions » Total Current Assets

Ananda Pharma (AQSE:ANA) Total Current Assets : £0.28 Mil (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Pharma Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Ananda Pharma's total current assets for the quarter that ended in Jul. 2023 was £0.28 Mil.


Ananda Pharma Total Current Assets Historical Data

The historical data trend for Ananda Pharma's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Total Current Assets Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Total Current Assets
0.32 0.13 0.01 0.11 0.28

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.05 0.11 0.04 0.28 0.28

Ananda Pharma Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Ananda Pharma's Total Current Assets for the fiscal year that ended in Jan. 2023 is calculated as

Ananda Pharma's Total Current Assets for the quarter that ended in Jul. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Ananda Pharma  (AQSE:ANA) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Ananda Pharma's Liquidation Value for the quarter that ended in Jul. 2023 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.012-2.929+0.75 * 0.222+0.5 * 0
=-2.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Pharma Total Current Assets Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Pharma Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines